ArticleFrontiers in immunology2025

Correction: Case Report: Regenerative hepatic pseudotumor induced by tislelizumab in a lung cancer patient.

Wenrui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.